Advanced

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Beyer, J.; Albers, P.; Altena, R.; Aparicio, J.; Bokemeyer, C.; Busch, J.; Cathomas, R.; Cavallin-Ståhl, Eva LU ; Clarke, N. W. and Classen, J., et al. (2013) In Annals of Oncology 24(4). p.878-888
Abstract
In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus... (More)
In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
consensus conference, diagnosis, germ-cell cancer, late toxic effects, long-term follow-up, treatment
in
Annals of Oncology
volume
24
issue
4
pages
878 - 888
publisher
Oxford University Press
external identifiers
  • wos:000316701300003
  • scopus:84875591927
ISSN
1569-8041
DOI
10.1093/annonc/mds579
language
English
LU publication?
yes
id
0da22759-f4ef-4a6c-bc90-571540ede61f (old id 3749590)
date added to LUP
2013-05-20 15:56:09
date last changed
2019-06-16 04:07:03
@article{0da22759-f4ef-4a6c-bc90-571540ede61f,
  abstract     = {In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.},
  author       = {Beyer, J. and Albers, P. and Altena, R. and Aparicio, J. and Bokemeyer, C. and Busch, J. and Cathomas, R. and Cavallin-Ståhl, Eva and Clarke, N. W. and Classen, J. and Cohn-Cedermark, G. and Dahl, A. A. and Daugaard, G. and De Giorgi, U. and De Santis, M. and De Wit, M. and De Wit, R. and Dieckmann, K. P. and Fenner, M. and Fizazi, K. and Flechon, A. and Fossa, S. D. and Germa Lluch, J. R. and Gietema, J. A. and Gillessen, S. and Giwercman, Aleksander and Hartmann, J. T. and Heidenreich, A. and Hentrich, M. and Honecker, F. and Horwich, A. and Huddart, R. A. and Kliesch, S. and Kollmannsberger, C. and Krege, S. and Laguna, M. P. and Looijenga, L. H. J. and Lorch, A. and Lotz, J. P. and Mayer, F. and Necchi, A. and Nicolai, N. and Nuver, J. and Oechsle, K. and Oldenburg, J. and Oosterhuis, J. W. and Powles, T. and Rajpert-De Meyts, E. and Rick, O. and Rosti, G. and Salvioni, R. and Schrader, M. and Schweyer, S. and Sedlmayer, F. and Sohaib, A. and Souchon, R. and Tandstad, T. and Winter, C. and Wittekind, C.},
  issn         = {1569-8041},
  keyword      = {consensus conference,diagnosis,germ-cell cancer,late toxic effects,long-term follow-up,treatment},
  language     = {eng},
  number       = {4},
  pages        = {878--888},
  publisher    = {Oxford University Press},
  series       = {Annals of Oncology},
  title        = {Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer},
  url          = {http://dx.doi.org/10.1093/annonc/mds579},
  volume       = {24},
  year         = {2013},
}